Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapy of aggressive behavior

D J Pabis1, S W Stanislav

  • 1College of Pharmacy, University of Texas, Austin, USA.

The Annals of Pharmacotherapy
|March 1, 1996
PubMed
Summary

Pharmacotherapy is key for managing aggressive behavior when behavioral interventions fail. Lithium or propranolol are recommended first-line treatments for aggression in patients without other psychiatric conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the usage of droperidol in acutely agitated persons with brain injury.

Brain injury·2000
Same author

Papular rash and bilateral pleural effusion associated with clozapine.

The Annals of pharmacotherapy·1999
Same author

Dystonia associated with sertraline.

Journal of clinical psychopharmacology·1999
Same author

Validity of a cognitive computerized assessment system in brain-injured patients.

Brain injury·1999
Same author

Cerebrospinal fluid monoamine metabolites and glucose metabolism in posttraumatic aggression.

Biological psychiatry·1998
Same author

Cognitive effects of antipsychotic agents in persons with traumatic brain injury.

Brain injury·1997

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Aggressive behavior is a complex issue with various contributing factors.
  • Understanding the neurochemistry and psychobiology of aggression is crucial for effective treatment.
  • Pharmacologic interventions are often necessary when behavioral therapies are insufficient.

Purpose of the Study:

  • To comprehensively review the definition, characteristics, prevalence, etiology, neurochemistry, and pharmacologic treatment of aggressive behavior.
  • To provide evidence-based recommendations for using specific pharmacologic agents in managing aggression.
  • To address the specific challenges of treating aggressive behavior in elderly populations.

Main Methods:

  • Systematic review and synthesis of English-language literature from MEDLINE.
  • Inclusion of clinical trials, case reports, letters, and review articles on aggression etiology and pharmacotherapy.
  • Focused review on specific pharmacotherapies and patient populations, including the elderly.

Main Results:

  • Pharmacotherapy is a primary treatment for aggressive patients, often initiated alongside nonpharmacologic interventions.
  • Short-acting benzodiazepines and high-potency antipsychotics are effective for acute aggression.
  • Long-term management of chronic aggression may benefit from agents like lithium, beta-blockers, carbamazepine, valproic acid, buspirone, trazodone, SSRIs, and clozapine.

Conclusions:

  • Lithium or propranolol are recommended as first-line antiaggressive agents for patients without comorbid psychiatric disorders.
  • A minimum trial of 6-8 weeks at maximum tolerated dosages is advised to assess drug efficacy.
  • Regular reevaluation (every 3-6 months) and attempts at medication tapering are recommended for patients responding to treatment.

Related Experiment Videos